Skip to main content
. 2023 Mar 25;45(4):2767–2780. doi: 10.3390/cimb45040181

Table 2.

Frequencies of study variables in our study with regard to prostate carcinoma.

Prostate Carcinoma Number of Cases %
P63 Negative 134 100%
AMACR Negative 6 4.5%
Positive 128 95.5%
PTEN (Pca) Score 0 68 50.7%
Score 1 56 41.8%
Score 2 10 7.5%
ERG (Pca) Negative 78 58.2%
Positive 56 41.8%